Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Mexico
  4. Mexican Stock Exchange
  5. Genomma Lab Internacional, S.A.B. de C.V.
  6. Summary
    LAB B   MX01LA010006

GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.

(LAB B)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Mexican Stock Exchange
09/10/2021 09/13/2021 09/14/2021 09/15/2021 09/17/2021 Date
21.08 20.84 20.93 20.66 20.85 Last
1600606 708372 1645780 943198 6082653 Volume
-1.26% -1.14% +0.43% -1.29% +0.92% Change
Estimated financial data (e)
Sales 2021 14 781 M 738 M 738 M
Net income 2021 1 645 M 82,2 M 82,2 M
Net Debt 2021 3 658 M 183 M 183 M
P/E ratio 2021 13,4x
Yield 2021 1,37%
Sales 2022 16 360 M 817 M 817 M
Net income 2022 2 143 M 107 M 107 M
Net Debt 2022 3 003 M 150 M 150 M
P/E ratio 2022 10,5x
Yield 2022 2,74%
Capitalization 21 020 M 1 051 M 1 050 M
EV / Sales 2021 1,67x
EV / Sales 2022 1,47x
Nbr of Employees 1 451
Free-Float 70,9%
More Financials
Company
Genomma Lab Internacional SAB de CV is a Mexico-based over-the-counter pharmaceutical (OTC pharmaceutical), generic drugs (GD) and personal care products company. The Company is engaged in the development, distribution and marketing of a range of products within different brands, for such treatments as anti-acne, varicose vein, hair loss, sexual stimulation and influenza; as well as analgesics and antifungals. The... 
Sector
Pharmaceuticals
Calendar
10/27Earnings Release
More about the company
Ratings of Genomma Lab Internacional, S.A.B. de C.V.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.
09/07GENOMMA LAB INTERNACIONAL B DE C : Receives Good Manufacturing Practices (GMP) C..
PU
08/04GENOMMA LAB INTERNACIONAL B DE C : External Auditor Ratification
PU
07/28GENOMMA LAB INTERNACIONAL B DE C : Q2 2021 Earnings Release
PU
07/28Genomma Lab Internacional, S.A.B. De C.V. Reports Earnings Results for the Se..
CI
07/28TRANCHE UPDATE ON GENOMMA LAB INTERN : LAB B)'s Equity Buyback Plan announced on..
CI
07/13GENOMMA LAB INTERNACIONAL B DE C : 2Q-2021 Earnings Call Advisory
PU
04/28TRANCHE UPDATE ON GENOMMA LAB INTERN : LAB B)'s Equity Buyback Plan announced on..
CI
04/28Genomma Lab Internacional, S.A.B. De C.V. Reports Earnings Results for the Fi..
CI
02/24Genomma Lab Internacional, S.A.B. De C.V. Reports Earnings Results for the Fo..
CI
02/24TRANCHE UPDATE ON GENOMMA LAB INTERN : LAB B)'s Equity Buyback Plan announced on..
CI
2020TRANCHE UPDATE ON GENOMMA LAB INTERN : LAB B)'s Equity Buyback Plan announced on..
CI
2020Genomma Lab Internacional, S.A.B. De C.V. Reports Earnings Results for the Th..
CI
2020Genomma Lab Internacional, S.A.B. de C.V. Informs Total Prepayment of Lab 18 ..
CI
2020Genomma Lab Internacional, S.A.B. De C.V. Reports Earnings Results for the Se..
CI
2020TRANCHE UPDATE ON GENOMMA LAB INTERN : LAB B)'s Equity Buyback Plan announced on..
CI
More news
News in other languages on GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.
09/07GENOMMA LAB INTERNACIONAL B DE C : Recibe Certificación de Buenas Prácticas de M..
08/04GENOMMA LAB INTERNACIONAL B DE C : Ratificación de Auditor Externo
08/03GENOMMA LAB INTERNACIONAL B DE C : Int. informa ratificación de auditor externo ..
07/28GENOMMA LAB INTERNACIONAL B DE C : Reporte de Resultados 2T 2021
07/13GENOMMA LAB INTERNACIONAL B DE C : 2T-2021 Invitación a Conferencia de Resultado..
More news
Chart GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.
Duration : Period :
Genomma Lab Internacional, S.A.B. de C.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 20,85 MXN
Average target price 26,23 MXN
Spread / Average Target 25,8%
EPS Revisions
Managers and Directors
Jorge Luis Brake Valderrama Chief Executive Officer
Antonio Zamora Galland Vice President-Administration & Finance
Rodrigo Alonso Herrera Aspra Chairman
Marco Sparvieri Chief Operating Officer & Executive Vice President
Juan Alonso Independent Director
Sector and Competitors
1st jan.Capi. (M$)
GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.10.67%1 051
JOHNSON & JOHNSON4.68%433 701
ROCHE HOLDING AG10.97%321 442
PFIZER, INC.19.23%246 078
NOVO NORDISK A/S50.80%232 556
ELI LILLY AND COMPANY36.28%208 604